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Abstract
Background: Severe mental illnesses like schizophrenia and bipolar disorder are known to be diseases that to
some extent, but not entirely can be understood genetically. The dominating hypothesis is that these disorders
should be understood in a neurodevelopmental perspective where genes and environment as well as gene-
environment-interactions contribute to the risk of developing the disease. We aim to analyse the influences of
genetic risk and environmental factors in a population of 520 7-year-old children with either 0, 1 or 2 parents
diagnosed with schizophrenia spectrum psychosis or bipolar disorder on mental health and level of functioning.
We hypothesize that a larger proportion of children growing up with an ill parent will display abnormal or delayed
development, behavioural problems or psychiatric symptoms compared to the healthy controls.
Methods/design: We are establishing a cohort of 520 7-year-old children and both their parents for a
comprehensive investigation with main outcome measures being neurocognition, behaviour, psychopathology and
neuromotor development of the child. Parents and children are examined with a comprehensive battery of
instruments and are asked for genetic material (saliva or blood) for genetic analyses. The participants are recruited
via Danish registers to ensure representativity. Data from registers concerning social status, birth complications,
somatic illnesses and hospitalization are included in the database. Psychological and relational factors like emotional
climate in the family, degree of stimulation and support in the home and attachment style are also investigated.
Discussion: Data collection started January 1, 2013, and is successfully ongoing. By Aug 2015 424 families are
included. About 20 % of the invited families decline to participate, equal for all groups.
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Introduction
Schizophrenia and bipolar disorder are among the most
severe and disabling mental disorders, influencing both
patients, relatives and society [1]. Our knowledge about
the etiology and development of these diseases is still
limited and therefore prevention strategies are not spe-
cific or proven effective.
It has recently been shown that mental diseases like
schizophrenia, major depression and bipolar disorder
may be quite closely related genetically, meaning that
there is a considerable genetic overlap between the three
different diagnoses [2]. Based on this recent meta-
analysis it was found that offspring of parents with one
of the mentioned diseases not only had an increased risk
of developing the same illness as their ill parent, but also
an increased risk of developing the other two disorders.
Schizophrenia is known as a severe and complex mental
disorder, most likely caused by several interacting genetic
and environmental factors, each having only a limited ef-
fect and predictive value. The dominating hypothesis is
that schizophrenia is a neurodevelopmental disorder [3].
The genetic contribution to the etiology of schizophrenia
is among the best investigated in psychiatry and is well-
documented in family, twin and adoption studies as well
as in GWAS studies [4]. Also, studies have shown that
genetic risk factors and environmental factors may inter-
act with and be influenced by each other and thus also in-
fluence the risk of developing psychosis or bipolar
disorder [5].
Children born to parents with bipolar disorder also have
an increased risk of developing other mental disorders
and specifically early-onset bipolar spectrum disorders
[6, 7]. Most adults with bipolar disorder experience
their first mood symptoms before the age of 21 years,
whereas most children at high genetic risk who de-
velop bipolar disorder later in life show manifest
symptoms of the disorder much earlier, often before
the age of 12 years.
Objectives
The aims of the Danish High Risk and Resilience
Study-VIA 7 are:
1) to analyse the influences of familial risk and
environmental factors, including rearing conditions in
childhood among a population of 7-year-old
children with either 0, 1 or 2 parents diagnosed
with schizophrenia spectrum psychosis or bipolar
disorder, especially focusing on psychopathology,
cognition, neuromotor, and psychosocial development;
2) to identify early risk markers of schizophrenia and
bipolar disorder to establish a basis for future
primary preventive interventions in the premorbid
phase;
3) to get an overview of the kind and the intensity of
help and support that the families have received
from the community from the time when the child
was born until the age of 7.
Background
Optimal designs for investigating gene-environment
interactions
The high risk approach
Theoretically, optimal designs for investigating inter-
action between environmental and genetic risk factors in
childhood and adolescence with respect to development
of schizophrenia or bipolar disorder, would be random-
ized clinical studies with the individuals being exposed
to poor environmental conditions, or adoption or twin
studies. However, randomized clinical studies are not
ethically acceptable and adoption studies with monozy-
gote twins growing up under different conditions, are
very rare.
Early signs of psychopathology and development of
schizophrenia or bipolar disorder are rarely found in the
general population, which makes studies of populations
with an increased risk profile (‘high risk studies’) highly
relevant for investigating the development of these disor-
ders and the influence of genetic risk. One of the most
famous studies in the field of schizophrenia research is
‘The Copenhagen High Risk Project’ [8], which so far is
one of the largest studies, covering 207 children of
mothers diagnosed with schizophrenia. It was started in
1962, when the children were on average 15 years old,
and the study has contributed to our current knowledge
with considerable and important results. One of its
major contributions was to show that schizophrenia was
at least partly familial. It was also one of the first studies
to show the specific impairments in these children at
high risk in domains of e.g. neuromotor development,
behaviour, cognition and emotional problems [9, 10].
Antipsychotic medication was not introduced until the
early fifties [11], thus making it is likely that the majority
of the parents who participated at that time were not
treated with antipsychotics in the early years of the chil-
dren’s lives. In other words, they may have been quite
severely ill and impaired by their psychotic symptoms in
the early years of the children’s lives.
However, much has happened since 1962 - both con-
cerning fundamental genetic understanding, diagnostic
procedures, methods for measuring neurocognition and
in terms of treatment of the disease. The social under-
standing in society and the public attitude towards psy-
chiatric patients have changed, although stigma and
isolation are still major issues. More insight into the di-
verse psychopathology, the neurocognitive deficits and
the psychosocial development of children who later ex-
perience an onset of schizophrenia has emerged. We
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therefore found it relevant and important to use this
knowledge in the design of a new high risk study of
about the same size and to start examining these chil-
dren at an even earlier age. Further, it is relevant to use
up-to-date, validated and reliable methods capturing the
special aspects of development that are relevant for this
group.
It lies outside the scope of this paper to review all
existing familial high risk studies, although relevant. For
the earliest studies, the so called first generation HR-
studies a thorough review [12] reports a generalized ten-
dency to find developmental delays and a variety of
problems or difficulties that these children may experi-
ence already during middle childhood and adolescence.
These include neurointegrative problems, social impair-
ments, early syptomatology, and deficits in attention
processing and neuromotor functions. Also the emerging
evidence for the influence of family enviroment is under-
lined. A need for future work to clarify developmental
patterns within the same individuals is emphasized. A
later review from 2003 is in accordance with these early
results [13]. However, in general, the field is character-
ized by different designs and several shortcomings, e.g.
only children with an affected mother, children with an
affected 1st degree relative, few or no follow-ups, and
widespread age groups sometimes with small number of
participants. For example the Rochester Family Study
[14], the Swedish High Risk Study [15] and the Emory
University Project [16] all included only between 25 and
61 HR subjects. The Helsinki High Risk Study [17] in-
cluded 204 schizophrenia HR children and 204 controls
and performed follow-up after 15 years. The group be-
hind the Boston National Collaborative Perinatal Project
HR Study (BNCPP [18]) and the Harvard Adolescent
High Risk Study [19] has published several papers re-
cently including follow-ups. The Edinburgh High Risk
Study has a slightly different approach since it includes
children with 2 or more 1st og 2nd degree relatives and
has done quite long follow-ups. Also the Israeli High
Risk Study (IHRS [20, 21]) and the Jerusalem Infant De-
velopment Study (JIDS) [22] deserve mentioning for
contributing to the current knowledge. All the studies
are pointing in the same direction supporting the neuro-
developmental hypothesis, but no study has to our
knowledge been made with all children having the same
age, including genetic material in combination with a
thorough estimate of environmental factors on a repre-
sentative cohort.
More recently, research concerning bipolar disorder has
started to look at the same patterns, although it has long
been well known that a family history of bipolar disorder
is the strongest known risk factor for developing the dis-
order. For example, it has been found that children with
familial risk for developing bipolar disorder may show
early signs of vulnerability [23]. This is seen as higher rates
of anxiety, sleep and mood disorders in childhood and as
an increased risk for developing substance abuse in ado-
lescence. These children also show elevated levels of psy-
chopathology and behavioral problems compared to
children of non-bipolar parents [24]. There is evidence
that those individuals who later develop bipolar disorder
report early signs of illness long before adulthood [25]. As
with schizophrenia a staging model has been proposed
with four stages from well-being to ill, starting in the early
ages of childhood with anxiety and sleep disorder, moving
to adjustment problems and subaffective states before
major depression, ending up in fullblown bipolar disorder
[26]. Researchers in this field emphasize the need of a de-
velopmental perspective to understand more about the
origin of this severe mental disorder and about possibil-
ities for preventive interventions [27–29].
Several environmental factors in both the prenatal and
the perinatal periods as well as through infancy and
childhood are associated with the risk of developing
schizophrenia later in life. This concerns factors regard-
ing the physical environment, e.g. intrauterine infections,
complications during pregnancy and birth, or growing
up in an urban district [30, 31]. It is also relevant to
study factors that influence the child’s psychological de-
velopment, such as the psychosocial and emotional en-
vironment and the everyday surroundings of the child
(e.g. growing up in an institution), the degree of illness
severity and chronicity of the ill parent, the emotional
climate in the family, and experiences of childhood
trauma [13, 32, 33]. Offspring of parents suffering from
a severe mental illness such as schizophrenia or bipolar
disorder are at a higher risk of growing up under adverse
circumstances and experiencing traumatic life events
(including the possibility of losing contact with one or
both parents), which may result in disturbances in at-
tachment and in normal, early cognitive and emotional
development [34]. Only few studies have explored the
levels of the parents’ psychopathology and their ability
to function as caregivers. The associations between the
severity and course of illness of the parent, and the rearing
circumstances of the child with neurological, cognitive,
behavioural and psychopathological risk markers in early
childhood have not been specifically investigated before.
Early markers of severe mental disorder
Individuals who later develop schizophrenia, show sev-
eral characteristics during childhood on a group level.
This includes lower IQ, cognitive deficits, delayed neuro-
motor development, language developmental difficulties,
emotional problems and poorer social function in child-
hood as established in longitudinal high risk studies and
birth cohort studies [13, 35–43]. Among the most fre-
quently reported characteristics in children at genetic
Thorup et al. BMC Psychiatry  (2015) 15:233 Page 3 of 15
high risk is poor cognitive and neurological functioning.
Due to their stability and the high correlation with the
underlying genetic burden, these characteristics may be
considered as ‘endophenotypes’ that reflect their specific
underlying genetic vulnerability [13, 44, 45]. Cognitive
dysfunction, poor affective control, and subtle psychosis-
like symptoms (PLIKS) are predictors for later develop-
ment of psychosis in children at genetic risk for schizo-
phrenia [42, 46]. Also, minor physical anomalies (MPAs)
have been shown to be associated with an increased risk
of psychosis [47].
For patients with bipolar disorder the literature points
out that these patients have more frequently had atten-
tion deficits and disruptive disorders, increased rates of
misuse in adolescence, as well as increased rates of anx-
iety disorders before the onset of the disease [48]. From
this longitudinal, prospective study with 141 offspring
(age 12–21) of families with a proband with BP, the authors
conclude that anxiety and externalising diagnoses predict
major affective illness in adolescence. The presence of syn-
dromal depression, ADHD, disruptive behavioural disor-
ders, and cyclothymic hypersensitive temperamental traits
are found to be risk factors for future development of bipo-
lar disorder, although most subjects exhibiting these traits
or states do not develop the disease [25].
Method
Settings
We will establish a cohort of 520 7-year-old children from
Denmark with different genetic risk profiles of schizophre-
nia and bipolar disorder in a follow-up design.
Participants
We will conduct a thorough examination of 520 children
aged 7 with either 0, 1 or 2 parents diagnosed with
schizophrenia spectrum psychosis, which we define as
schizophrenia, delusional disorder or schizoaffective dis-
order (ICD 10-codes: F20, F22 and F25 or ICD 8-codes:
295, 297, 298.29, 298.39, 298.89, 298.99) or bipolar dis-
order (defined as ICD 10 code F31 or ICD 8-codes:
296.19, 296.39). All children must be born in Denmark
to ensure that full information via register data from
both parents is accessible; − this is necessary to limit
stratification in the genetic analyses. Analyses combining
data from the Danish CPR Register (Civil Registration
System [49]) and the Danish Psychiatric Central Re-
search Register [50] show that each year approximately
200 7-year-old children are from families where at least
one parent is affected with schizophrenia or schizophre-
nia spectrum psychosis. The number of children with
one parent with bipolar disorder is expected to be simi-
lar. Approximately 20–30 7-year-old children have two
parents diagnosed with either schizophrenia or schizo-
phrenia spectrum psychosis and/or bipolar disorder in
Denmark every year. During an inclusion period of ap-
proximately three years, we will randomly select the fol-
lowing stratified sample of 520 7-year-old children from
all parts of Denmark for examination:
a) at least one parent, either a mother or a father,
diagnosed and registered with a schizophrenia
spectrum psychosis; N = 200.
b) at least one parent, either a mother or a father,
diagnosed and registered with bipolar disorder;
N = 120.
c) neither of the parents being treated or registered in
mental health services as in- or outpatients for the
above-mentioned diagnoses; N = 200.
Group (a), (b), and (c) will be matched on urbanicity,
community, gender and exact age of the child. Among the
children included in group (a) or (b) 30–40 children are ex-
pected to have two ill parents, and form a special subgroup
within the final cohort. The reasons for including a group
of low risk controls are to evaluate gene-environment inter-
actions with a control group and to create Danish norms
for some of the outcome measures. Finally, this makes it
possible to keep the child’s risk status concealed for the
child investigator, thus not introducing bias due to specific
expectations towards the child.
Age seven
The reason for choosing age 7 is that most children in
Denmark have started school at this age, which thus rep-
resents an important developmental step for the child.
Starting school is characterized by increased demands
on the child, cognitive and academic, as well as social
and practical. From a neurocognitive perspective this
phase of a child’s life is characterized by a very rapid
cognitive development, e.g. in the frontal lobes as dem-
onstrated in a metaanalysis [51]. At the same time the
early development of the child is not too distant to be
recalled for the parent being interviewed.
Exposures
Genetic exposure, polygenic risk scores and family history
The Danish Neonatal Screening Bio-bank is a national bio
bank holding dried blood spot-samples from all new-borns
since 1981 collected for genetic testing for e. g. phenylke-
tonuria [43, 48–50]. All children in VIA 7 are identified in
the Danish Neonatal Screening Bio-bank, their DNA ex-
tracted, whole-genome amplified and genotyped on the
Illumina PsychChip, which is a whole-genome SNP array
developed in collaboration with the Psychiatric Genetics
Consortium (PGC) for genome wide association studies
(GWAS). The data is processed using the bioinformatics
pipeline of PGC. Similarly, DNA from blood samples from
their parents is genotyped on the same platform. Polygenic
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risk scores predict case–control status in GWASs of
schizophrenia [52, 53]. Constructed from risk alleles at
thousands of genetic loci, the polygenic risk scores config-
ure a simple and robust technique to study at a population
level an individual’s genetic risk for polygenic traits, e. g.
schizophrenia or bipolar disorder. Here, we will test if
polygenic risk score alone and in combination with family
history is associated with antecedents of schizophrenia or
bipolar disorder and any observed associations of environ-
mental exposures. Furthermore, it is possible to use the
DNA from the blood spots and from saliva samples at age
seven for genome-wide studies of methylation status at
birth compared to age seven using the Infinium Human-
Methylation450 BeadChip Kit (Illumina). Thus in VIA 7
we will be able to compare the epigenetic blueprint at birth
with status at age seven and at later follow-ups. This may
allow us to identify signatures of environmental exposures.
Environmental exposures
We aim to study biological, social and emotional expo-
sures during the prenatal, perinatal, and infant period
and in childhood. The prenatal and perinatal conditions
of interest are maternal use of medication, tobacco,
drugs and alcohol during pregnancy: pregnancy and
birth complications and subjective constraints/stressors
in the mother’s life. Specific environmental predictors
will be extracted from registers, e.g., parental age (CPR
register), birth complications (Danish Medical Birth
Register/Danish National Hospital Register) [54] or identi-
fied through interviews with the mother. The combination
of informant-based information concerning their current
and earlier health status and other relevant life events, to-
gether with the information derived from registers, will
enable us to make a more consistent quantification of
several important pre- and perinatal exposures and
confounders during pregnancy and up to age seven.
The biological exposures which play a role during infancy
and childhood are among others neuro infections, cranial
trauma or other severe somatic diseases, and failure to
thrive. This information will be extracted from the Danish
National Hospital Register [55], and from interviews with
the mother/caregiver.
The social and emotional exposures like growing up with
a parent with a severe mental disorder, number of changes
in address and in institution/kindergarten, removal from
home, parents’ social and financial status, prenatal stress,
early postnatal rearing conditions, divorce and death of a
close relative etc. will be collected. Some of these exposures
can be extracted from complete longitudinal national regis-
ters (Statistics Denmark, IDA database [56]), some will be
obtained from interviews.
Psychopathology as an exposure: Both biological par-
ents and other important adults living with the child will
be examined with Present State Examination [57] to
assess current and life time mental health status. If the
parent has ever had any symptoms of depression, mania,
psychosis or negative symptoms, the symptom level of
the present month will be rated, too, (depression by
Hamilton Depression Scale [58], mania by Young Mania
Rating Scale [59] and psychotic symptoms by Schedule
for Assessment of Positive Symptoms (SAPS [60]) and
negative symptoms by Schedule for Assessment of Nega-
tive Symptoms (SANS [61]).
The rearing environment will be studied in different
ways. The emotional climate surrounding the child is
measured through an interaction test with caregiver and
child and by home visits (see section 3.6 Instruments
and outcomes and Table 1, 2, and 3 for details).
Registers and bio-banks
A)The Danish Civil Registration System [49] was
established in 1968. All persons alive and living in
Denmark are registered and assigned a 10 digit
unique and personal identification number.
Furthermore, data on gender, date of birth, place of
birth, continuously updated information on vital
status (e.g. date of death and migration out of
Denmark), and identity of parents, siblings, children
and spouses are recorded, as are the addresses of
each individual from 1972 and onwards.
B) The Danish Psychiatric Central Research Register:
Data on psychiatric admissions in Denmark have
been collected systematically since 1938. From April
1, 1969 these data were computerized and include
all admissions to psychiatric hospitals. From January
1, 1995 outpatient contacts were included [50].
C) The Danish Medical Birth Register [54] covers
information on all births in Denmark since 1973. It
contains information on foetal presentation, earlier
pregnancies, delivery, length, birth weight and weeks
of gestation. It is now included as a part of The
National Hospital Register [55], which was
established in 1978 and information about all
admissions to public hospitals in Denmark was
prospectively recorded. Since 1995, outpatient visits
were also registered.
D)The IDA Database [56], a Danish acronym for
Integrated Database for Labour Market Research,
contains longitudinal information on labour market
conditions, automatically extracted from official
records for all persons in the population, and their
socio-demographic data.
E) The Children Register (http://esundhed.dk/
sundhedsregistre/BDB/Sider/BDB.aspx), Statistics
Denmark contains information about children whose
parents lost custody of them and supportive
interventions from the local authorities.
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F) On the basis of the samples from the Danish
Neonatal Screening Bio-bank, DNSB, it has been
documented that whole genome amplification of
DNA can be performed, and that fine mapping of
candidate genes as well as genome-wide association
analysis are possible [62, 63]. Furthermore, specific
antibodies against infectious agents as well as a
number of cytokines and inflammatory markers can
be measured [64, 65]. This will enable us to make an
exact measurement of several important exposures
and confounders, direct measurement of genetic
markers of relevance for infections or schizophrenia/
bipolar affective disorders compared to data on
family history, and will dramatically change the
precision and interpretability in comparison to most
studies currently available.
Instruments and outcomes
The children will be assessed with a number of instru-
ments to evaluate neuromotor and neuro- and social
cognitive functions, behaviour and psychiatric symptoms
[66, 67]. All outcome measures will be examined with
validated instruments, specifically developed and se-
lected for this young age group, sensitive to small
changes and suitable for later follow-up, if relevant
(see Tables 1 and 2).
Table 1 Instruments used for the assessment of the neuromotor and cognitive domains of the 7-year-old children participating in
the Danish High Risk and Resilience Study-VIA 7
Domains Subdomains Child Caregiver Teacher
Neuromotor and
physical measures




do Height, weight, head circumference,
arm span
Motor speed and dexterity Finger tapping [82]
Grooved Pegboard [83]
Minor physical anomalies (MPAs) Waldrop Scale [103], 3D photo
Cognition Verbal memory and visual memory Word Selective Reminding and Memory for
Stories from Tomal-2 [85], RCFT: Rey Complex
Figure Test and Recognition Trial [86]
Attention RVP (rapid visual information processing;
3-5-7 mode) from CANTAB [88]. Conners
CPT (Continuous Performance Test [96])
Receptive and expressive language
(incl. grammar and pragmatic aspects)
TROG-II (Test for Reception of Grammar, [93]) CCC (Children’s
Communication
Checklist-II [112])
Speed of Processing Verbal Fluency and Trails A/B from D-KEFS [91]




SOC (Stockings of Cambridge) and IED (Intra-
Extra Dimensional Shift test) from CANTAB [88].
Executive functions (visual
and verbal working memory)
SSP (Spatial Span) and SWM (Spatial Working
Memory) from CANTAB [88] + Letter-number




Social cognition Revised Happe’s Strange Stories [100], Animated
Triangles [101] and ERT (Emotion Recognition
Task) from CANTAB [88]
Intelligence RIST (Reynolds Intellectual Screening Test [92])
Visual selective attention and
perceptual speed
Visual Attention Battery from University of
Copenhagen [99]
Smell identification B-SIT (Brief Smell Identification Test, [94])
Imagination/creativity Pattern Meanings [95]
Decision making CGT (Cambridge Gambling Task) from
CANTAB [88]
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The main outcomes and how they are captured are
listed below:
– different psychiatric and emotional symptoms:
anxiety, depression and obsessive symptoms,
attention deficits and conduct disorders, psychotic
and attenuated psychotic symptoms from K-SADS-PL
(Schedule for Affective Disorders and Schizophrenia
for School-Age Children [68]) and from CBCL (Child
Behaviour Checklist [69, 70]), ADHD-RS (Attention
Deficit Hyperactivity Disorder Rating Scale, Du Paul
[71, 72]. PLIKS (Psychosis like symptoms) are covered
by the psychosis supplement from K-SADS-PL, which
is done with all children; no matter what they answer
in the screening interview (cut-off is not used). A
special scale, the SIPS scale [73], is used to register the
milder, doubtful or subtle symptoms, e.g. rare and
very brief experiences of mild auditory hallucinations
like hearing someone calling his or her name etc.
The tester will fulfil the TOF (Test Observation
Form [74]) to include the clinical impression and
performance during testing.
– social function/behaviour: SDQ (Strength and
Difficulties Questionnaire [75], SRS (Social
Responsiveness Scale [76], Danish Version, Hogrefe,
Psykologisk Forlag, Copenhagen) and Vineland
Adaptive Behavior Scale II, (only the subscale
concerning social behaviour [77] is given to the
Table 2 Instruments used for the assessment of the psychiatric, behavioral and environmental domains of the 7-year-old children
participating in the Danish High Risk and Resilience Study-VIA 7











behavior and traumatic life
events
K-SADS-PL [68] K-SADS-PL [68] TRF (Teachers Rating
Form of Child Behavior
Checklist (CBCL [69])CBCL (Child Behavior
Checklist [69])
Attention/hyperactivity ADHD-Rating Scale [72] ADHD-Rating Scale [72]












Self-esteem and quality of life Kidscreen-27 ([78] and
‘Sådan er jeg’ (‘This is
how I am’ [113])
Stress Hair test for cortisol
Subjective stress Items from DLSS (Daily
Life Stressor Scale [79])







Behavior Scales –II [77]












Stimulation and support in actual
rearing environment
HOME Inventory [104] HOME Inventory [104]
Interaction with caregiver Tangram Puzzle [106] Tangram Puzzle [106]




Expressed emotions FMSS (Five Minute Speech
Sample [105])
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parents). Questionnaires concerning the child’s own
experiences and subjective viewpoints on self-esteem
(‘Sådan er jeg’ in Danish meaning ‘This is me’),
quality of life (Kidscreen, Danish Version, Hogrefe,
Psykologisk Forlag, Copenhagen 2011, [78]), perceived
stress (items from DLSS (Daily Life Stressor Scale [79])
and affect regulation/emotional control via selected
single items from the questionnaire CEMS (Children’s
Emotion Management Scales [80]) and STAIC [81].
– fine motor speed and dexterity (Finger Tapping Test
[82] and Grooved Pegboard [83]) and gross motor
skills (Movement Assessment Battery for Children-2:
Movement ABC −2 [84]).
– cognitive function: aspects of verbal memory (Test
of Memory and Learning, 2nd Edition: TOMAL-2
[85]) and visual memory (Rex Complex Figure Test:
RCFT [86]), executive functioning (Behavior Rating
Inventory of Executive Function, BRIEF [87]),
subtests of CANTAB (ERT: emotion recognition
task, RVP: rapid visual information processing,
SWM: Spatial Working Memory, SSP: Spatial Span,
SOC: Stockings of Cambridge, IED: Intra-Extra
Dimensional Shift test, CGT: Cambridge Gambling
Task [88, 89]), subtests from WISC-IV [90] and
D-KEFS (Delis-Kaplan Executive Function System
[91]), intelligence: Reynolds Intellectual Screening
Table 3 Instruments used for the assessment of the parents of the 7-year-old children participating in the Danish High Risk and
Resilience Study-VIA 7
Domains Ill parent Other parent Actual caregiver, if not parent
Mental health (life time) SCAN (Schedule for Clinical
Assessment in Neuropsychiatry
[57])
SCAN (Schedule for Clinical
Assessment in Neuropsychiatry [57])
SCAN (Schedules for Clinical
Assessment in Neuropsychiatry
[57])
Daily functioning PSP (Personal and Social
Performance Scale [114])
PSP (Personal and Social
Performance Scale [114])
PSP (Personal and Social
Performance Scale [114])
Actual state of illness SANS (Scale for the Assessment of
Negative Symptoms [61])
SANS (Scale for the Assessment of
Negative Symptoms [61])
SANS (Scale for the Assessment
of Negative Symptoms [61])
do SAPS (Scale for the Assessment of
Positive Symptoms [60])
SAPS (Scale for the Assessment of
Positive Symptoms [60])
SAPS (Scale for the Assessment
of Positive Symptoms [60])
do Hamilton Rating Scale for
Depression [58]
Hamilton Rating Scale for
Depression [58]
Hamilton Rating Scale for
Depression [58]
do YMRS (Young Mania Rating
Scale [59])
YMRS (Young Mania Rating
Scale [59])
YMRS (Young Mania Rating
Scale [59])
Affective regulation ALS (Affective Liability Scale [115]) ALS (Affective Liability Scale [115]) ALS (Affective Liability Scale [115])
Intelligence RIST (Reynolds Intellectual
Screening Test [92])





and speed of processing
Letter-Number sequencing and
coding from WAIS [116]
Letter-Number sequencing and
coding from WAIS [116]
Letter-Number sequencing and
coding from WAIS [116]
Executive functioning,
flexibility, risk taking
IED (Intra/Extra Dimensional Set
Shift test), SWM (Spatial Working
Memory), CGT (Cambridge
Gambling Task) and RVP (rapid
visual information processing;
3-5-7 mode) from CANTAB [88]
Smell identification B-SIT (Brief Smell Identification Test
[94])
Verbal fluency D-KEFS Verbal fluency [91]
Social cognition AT (Animated Triangles [101]),
TASIT-R (The Awareness of Social
Inference Test – Revised [117]), ERT
(Emotion Recognition Task) from
CANTAB [88]
Social functioning SPS (Social Provision Scale [109]) SPS (Social Provision Scale [109])
PAM (Psychosis Attachment
Measurement [118])
SPS (Social Provision Scale [109])
PAM (Psychosis Attacment
Measurement [118])PAM (Psychosis Attachment
Measurement [118])
Relation to child CHQ Caregivers Helplessness
Questionnaire [107]
Expressed emotions FMSS (Five minute speech sample)
Interaction with child Tangram Interaction test [106]
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Test: RIST ([92] Danish Version, Hogrefe, Psykologisk
Forlag, Copenhagen, 2011), impressive language
(Test for Reception of Grammar TROG-2 [93], smell
identification (B-SIT [94]) and creativity (Pattern
Meanings [95]).
– aspects of attention, error monitoring/early
information processing: Conners Continuous
Performance Test (Conners CPT [96] and Flanker
Test [97, 98], which is a modified Eriksen-flanker
paradigm implemented in E-prime 2 (Psychology
Software Tools, Pittsburgh, USA). Test for Visual
Attention [99] and aspects of social cognition (Emotion
Recognition Task (ERT) from CANTAB (Cambridge
Neuropsychological Automated Test Battery [88]),
Happe’s Strange Stories [100] and Animated Triangles
[101, 102]. For details, see Tables 1 and 2.
– A hair-sample will be used for cortisol analysis,
indicating level of stress of the child during the
previous three months, combined with interview
data. This part of the study is administered as part of
the Gene-Environment study and is optional.
– 3D photos of the children and the affected parent
will be taken for investigation of facial dysmorphism.
Examination of minor physical anomalies (MPAs) is
performed using the Waldrop Scale [103].
– investigation of the emotional climate and the home
environment in the families will take place in the
home using the HOME instrument (Home
Observation for Measurement of the Environment
[104]). This semi-structured interview focuses on
the level of support and stimulation in the child’s
home environment combined with direct observations.
A brief measure of the level of expressed emotions is
obtained from FMSS (Five Minute Speech Sample
[105]) and child–parent interaction is assessed by
means of an observation study of Tangram Puzzle test
[106]. The Tangram test is a test where the child is
asked to make a (very) difficult puzzle within 5 min.
The actual caregiver sits next to the child for support
and is told that the test is meant to reveal the child’s
cognitive skills. The interaction between the adult and
the child is videotaped and later coded from a manual).
The actual caregiver will be asked about her or
his degree of feeling helpless or out of control in
relation to the child by means of the Caregiver
Helplessness Questionnaire (CHQ [107]). The
Story Stem Assessment Profile [108] is suitable
for age 7 for measuring attachment style constructs of
the child. Also the parents’ perception of perceived
support from their social network will be included in
a questionnaire [109].
– exposure to illness/distress: The parents (and the
actual caregiver if not the parent) will be
interviewed with SCAN (Schedules for Clinical
Assessment in Neuropsychiatry [57]). Also
stepparents who have lived more than 12 months
with the child will be interviewed if they are willing
to participate. A timeline going 8 years back in time
(from pregnancy until now) will be used to register
the periods of mental problems of the parents
during the child’s life. The mother will be
interviewed in detail about pregnancy, and early
development (medication, alcohol, tobacco, adverse
life events, early regulation difficulties, milestones
etc.). Data on the actual socio-economic status will
be collected from the interview and drawn from
registers.
– adverse life events/childhood trauma: In the
anamnestic interview we ask the actual caregiver
about any adverse life events that may have happened
to the child. In the K-SADS-PL all questions about
experiences that could lead to PTSD are asked; they
include all kinds of stressing life events and trauma,
and they are registered, even if there is no PTSD.
Procedures
Seven Ph.D. students, three clinical assistants, three re-
search nurses and two postdocs are responsible for car-
rying out the clinical characterisation of the children
and the parents. The primary research nurse coordinates
administrative issues concerning the contacting of the
invited families, registers etc. A letter with a small folder
briefly describing the investigation is sent to the child’s
address. This is followed up by a phone call from the re-
search nurse a few days later, inviting the family to a
meeting to learn more about what the implications of
participation are. Both parents are asked for written, in-
formed consent before data collection can start. In case
of divorced parents, where both parents have custody of
the child, as is most common in Denmark, both parents
have to accept the child’s participation.
The genetic study ‘Gene Environment’ is presented as
a separate study that is optional for all participants and
has its own written consent form. The genotypic infor-
mation about the children is based on blood samples
from the Danish Neonatal Screening Bio-bank and for
the parents from whole blood or saliva samples, if con-
sent is given. These will be extracted at the time of the
examination of the children. Moreover, we also ask for
saliva samples from the children for epigenetic analyses.
However, we decided not to ask for fresh blood samples
from the 7-year-olds for psychological reasons.
Two researchers are assigned to each family, one test-
ing the child while the other (simultaneously, if possible)
conducts the interview with the primary caregiver. At
least one home visit in the family’s home is arranged if
the family accepts it. A very high degree of flexibility is
required when arranging the interviews to ensure high
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response rates. That means that the interviews can take
place wherever the family prefers them to take place. All
interviews are made face to face (not by telephone or
Skype). Best estimate diagnoses from the K-SADS-PL
interview are established at weekly conferences in the re-
search group with a specialist or professor in child- and
adolescent psychiatry present. Regular monthly meetings
are arranged for the entire group to measure inter-rater
reliability and to ensure that all instructions and manuals
are used correctly by all group members. We will measure
reliability of diagnoses and choice of supplement by hav-
ing all interviewers score ten K-SADS-PL interviews
(screening part) independently from each other.
All researchers are trained in the entire test battery
and can thus substitute for each other if necessary, but
continuity in the contact to the families is aimed for.
The researchers are blinded to high risk or control status
of the child to ensure objectivity in the assessment and
for ethical reasons, since some children may not be
aware that they have a parent who at some point had or
currently has a mental disease. The primary caregiver is
asked about the child’s development and actual status,
and all adults are interviewed about their own mental
health status and history. The interviews and the tests
will last approximately 7–8 hours (not including breaks
and meals) and are therefore spread over more than one
day, typically in 3–4 meetings of approx. 3 hours. The par-
ents and the child are offered compensation for taking the
time to participate by way of a gift card and transportation
is paid for. If the parents give permission, information
from the child’s primary teacher will also be obtained, see
Tables 1 and 2. All parents with a diagnosis of schizophre-
nia or bipolar disorder are asked to perform the large cog-
nitive battery, while the other parent does the small
cognitive assessment. In the control families one parent is
chosen to perform the larger cognitive battery, based on
matching with a schizophrenia high-risk family in terms
of child age and urbanicity, while the other parent does
the small cognitive battery. So, in all families one parent is
tested with the larger cognitive battery and one is tested
with the smaller battery (see also Table 3).
Under Danish law, we as professionals have an ex-
tended responsibility to provide help if needed. On the
other hand, since it has been made clear to all families
from the beginning, that this is not an intervention
study, this may on a few occasions lead to an ethical di-
lemma. We are aware of that in a few cases we feel a
need to give the family advice or make a written referral
in order to get the family some kind of help for them-
selves or their child.
Ethical approval and Danish Data Protection Agency
We asked the Danish National Committee on Health
Research Ethics for approval of the main study – VIA
7. However, under Danish law a study like this that
does not involve any kind of intervention or genetic
material, does not need an ethical approval. The Gene-
Environment part of the study obtained Ethical Approval
at the outset of the study and The Danish High Risk and
Resilience Study –VIA 7 was later incorporated into their
protocol as an appendix, which has then been approved
by the committee.
The project is approved by the Danish Data Protection
Agency and follows all laws concerning the processing
of personal data. We received permission to draw data
from registers from the Danish Ministry of Health.
Statistics
Analyses will be carried out using SPSS, statistical pack-
age 22.0 for Windows (SPSS Inc., Chicago, IL, USA). All
children will be divided into three main diagnostic
groups HR-sz (High Risk schizophrenia), HR-bip (High
Risk bipolar) and CTR (controls) based on ICD-10 diag-
noses of the parents from registers. We will carry out
descriptive analyses using standard statistical methods
(Pearson chi-square test, one-way ANOVA analyses,
Mann–Whitney U-tests whenever appropriate) investi-
gating differences in demographic characteristics, psy-
chiatric history, and phenotypic presentation. Linear
and logistic regression models will be used to adjust
for confounding factors and to investigate mediating
and moderating factors.
Status
Data collection started on 1 January, 2013 and is going on
successfully, because a majority of the invited families
accept to participate. By 1 August 2015, 424 families have
accepted to participate, and 83 have declined, including
some families that we were unable to contact since tele-
phone numbers could not be found. Those who decline to
participate are equally distributed between all three groups.
Almost all included families fulfil the comprehensive data
battery. Only eight families withdrew their consent after in-
clusion until July 2015. More than 80 % of the participants
of the VIA7 study also accept to participate in the Gene-
Environment Study by donating genetic material.
Discussion
This section will briefly discuss the advantages and the
limitations of our study. Also, we will mention a few
considerations about how this study fits into the concept
of developmental psychology and the newly defined and
still developing project RDoC (NIMH Research Domain
Criteria) that outlines new principles for how to capture
and understand mental illness in a more dimensional
way, not limited by traditional diagnostic boundaries.
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Strengths
 This study is to our knowledge the first study to
include such detailed information about the
environment of the child, including the thorough
description of the child’s development and
symptoms during the first 7 years of life.
 Our study is unique in that all children in the VIA 7
cohort have nearly the same age (within 12 months).
This gives us a very detailed level of information of
this exact age group, and also makes all comparisons
much more accurate.
 Further, this population based selection of cases and
controls at same age limits the heterogeneity of data
and will thus increase power, e.g. with respect to
environmental exposures. Data from Danish
Registers allow us to invite a more representative
sample of all high-risk children, since also parents,
who are not actively attending treatment, are invited.
 Our non-biased sampling of exposures supplemented
by detailed interviews will increase the validity of
exposures.
 The very comprehensive mapping of cognition,
psychopathology, MPA’s etc. will allow a thorough
description of multiple important domains of child
development.
 The interdisciplinary approach with data spanning
from genetics and biometry to home environment
and attachment measures is unique and allows
integrative analyses and multidisciplinary
interpretation.
 Participation rates are very high and drop-out rates
are negligible in spite of the time consuming battery.
 DNA material from the children are collected both
at birth and at age seven and will allow us to study
epigenetic changes over time and comprehensive
genotyping of risk alleles.
 The identification of biological signatures of exposures
in utero as measured at birth is absolutely unique.
 With a planned follow-up at age 11 we will be the
first ever to examine a large sample of HR-children
twice before adolescence, and we will be able to de-
scribe developmental trajectories in more detail than
any other study.
Limitations
Although participation rates are high, representativity
and selection bias have to be considered before drawing
any general conclusions from the results. About one fifth
of all invited families do not have a telephone number
that can be found online, which prevents us from getting
in contact with them. We could speculate that these are
the families with the most severe courses and most trou-
bled lives. But the situation might also be the reverse, i.e.
families where a diagnosis of severe mental illness be-
longs to the past and no longer influences their lives.
The clinical diagnoses from the registers are not al-
ways confirmed at the clinical research interview, leaving
us in doubt whether this person really did suffer from
e.g. schizophrenia at some point in the past, or whether
the register-based diagnosis was in fact wrong. We may
need to ask for permission to read all hospital records in
those cases to confirm the diagnosis.
This study is not meant to be an intervention study.
But from the feedback we already have received from
some of the participating families, it is clear that attend-
ing the interviews, telling their life history and reviewing
their child’s developmental history may in some cases re-
veal problems that need to be solved, or it may inspire
the families to introduce changes in their ways of living.
This will only affect the baseline data to a very limited
extent, but must be kept in mind at all follow-ups.
Perspectives
The perspectives for the VIA 7 study of children at age 7
are threefold.
First of all, we wish to characterize children at familial
risk with a wide range of clinical measures and a com-
prehensive neurocognitive battery to explore their char-
acteristics as a group and to identify endophenotypes at
age 7. This is relevant when planning health services
specially tailored for this group of vulnerable and often
overlooked children and their families. These families
are often struggling on two fronts: with the challenges of
normal family life and with a severe mental illness at the
same time. We will be able to identify and characterize
those children who already at age 7 show the first signs
of neurodevelopmental delay or abnormal discourse.
This will enable us to establish interventions and de-
velop better strategies to detect and relieve these diffi-
culties for children in a similar situation in the future
and maybe also to prevent further development into se-
vere mental illness.
Secondly, the long term perspective of the study is to
make follow-ups at age 11, 15 and 21 and further on for
the next decades, if possible, and thus learn more about
the children’s cognitive, emotional and social develop-
mental trajectories on a group level. A follow-up study
at age 11, called VIA 11, is already being planned and fi-
nancial support has been obtained. The follow-up will
include many of the same measures as in the VIA 7 but
also brain imaging (functional and MRI), which will pro-
vide very important information about the development
of the brain in relation to mental health and environ-
ment. Having two measure points before puberty is
unique to this study. At present we do not know if the
delays found at age 7 will level out at early puberty or if
they will progress over time to even lower levels.
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Finally, we aim to answer the question: who among
these children will in time develop a severe mental dis-
order, either the one, that they are predisposed for or an-
other mental disorder? And who will remain well? The
follow-up data will be able to provide important infor-
mation about protective factors, resilience and predictors
of mental health status in adolescence.
RDoC project
The design and the purpose of this study is entirely
aligned with the ideas that form the basis of the NIHM’s
RDoC Project [110]. The overall goal of the RDoC is to
develop a new classification of psychopathology based
on dimensions of neurobiology and behavioural mea-
sures. The basic principles are that mental illnesses are
disorders of brain circuits, that neuroscientific methods
can identify brain dysfunctions, and that knowledge
about disordered circuits will show the way for future
classification, assessment, and treatment. RDoC aims to
inspire research that focuses on dysfunction across do-
mains and levels of analysis. The domains that are in-
cluded at the moment are: negative valence, positive
valence, cognitive systems, system for social processes,
and arousal/modulatory systems. Levels of analysis could
be genes, molecules, cells, circuits, physiology, behaviour
and self-report. Two other dimensions that are crucial
to the RDoC project are developmental trajectories and
environmental effects. They often interact and should be
considered as integral parts of the structure.
The RDoC project is at its beginning, aiming to build a
database that will change the understanding of psycho-
pathology fundamentally. It has a new perspective on re-
search, cutting across diagnostic categories, a perspective
that is both useful and necessary when studying develop-
mental psychopathology and early signs of mental illness
[111]. The goals of this high risk study are to our convic-
tion nicely aligned with the RDoC initiative in two funda-
mental ways: First, we are interested in the continuum of
psychotic disorders and their expression. While we are
collecting clinical information regarding diagnosis, this
will help our data be compared to previous studies using
DSM or ICD diagnoses. Nevertheless, we believe that the
continuum of psychosis and its risk will be very well ex-
plored by our design. Second, the phenotypes we assess,
whether behaviour, cognition, and so on, are continuous
dimensions relevant to all psychotic disorders. While they
were not chosen explicitly using RDoC domains, we are
covering in some detail, some of those domains, such as
working memory, social cognition, or negative affect and
reward systems and thus our data will be informative
within an RDoC framework. For example, the domain of
negative valence/psychopathology is captured in the study
both as categorical data (the diagnoses given on the basis
of the K-SADS-PL interview) and as dimensional
measures on the CBCL (Child Behavior Checklis [69]) and
TRF (Teachers Rating Form [69]). The first gives us di-
chotomous data (diagnosis/no diagnosis), while the other
two are continual scores based on information from both
the actual caregiver’s and the actual teacher’s concerning
observed behaviour and problems of the child and indicat-
ing child psychiatric problems. Further, this will be com-
bined with the ratings of the clinical impression of the
child during the clinical testing (TOF; Test Observation
Form [74]) and will be followed up upon in VIA 11. In
terms of the RDoC domain called ‘cognitive systems’ we
have data covering all the subdomains (attention, percep-
tion, declarative memory, language behaviour, cognitive
control and working memory). All together this approach
to psychopathology is much in line with the developmen-
tal approach that the RDoC is based on. Further, with the
perspective of adding scans and blood tests at the 11-year
follow-up will give us information that fits into what
RDoC calls ‘cells’, ‘molecules’ and ‘circuits’.
Conclusion
This paper describes ’The Danish High Risk and Resili-
ence Study – VIA 7’ a cohort study of 520 7-year-old
children, who are born to parents with either schizo-
phrenia, bipolar disorder or neither of the two diagnoses.
We are aiming to capture both genetic factors and
environmental factors. We investigate the children’s neu-
romotor, neurocognitive, and social and behavioral func-
tioning as well as their psychiatric symptoms. We also
include data from the parents, from teachers and data
from Danish Registers.
It is quite unique that all children have the same age,
that participants are selected in a population based man-
ner and that we have two samples of genetic material from
the children. A follow-up at age 11 is planned to ensure
two measurements before puberty in all important do-
mains, which is unique, too.
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